Cannabis derivative refused licence in UK

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Cannabis derivative refused licence in UK

Postby JFH » Sat Jun 11, 2005 1:08 am

The Guardian is reporting today:

Cannabis spray for MS patients refused licence

... there had been great expectations of the medicine, produced as a nasal spray called Sativex, which had been undergoing trials for several years.

But the Medicines and Healthcare Products Regulatory Authority announced that the licence application to treat spasticity filed by GW Pharmaceuticals, which designed and manufactured the drug, had been turned down on appeal. The MHRA said there was not enough proof that the drug worked.

Full article,,1504170,00.html

Commentators are saying this is a non-scientific, ie political, decision. Since the UK is becoming increasingly an illiberal place to live this is probably true.
I am what I am
User avatar
Family Elder
Posts: 288
Joined: Sun Jul 11, 2004 3:00 pm
Location: England


Return to Sativex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service